1. Regulation of the H+-ATP synthase by IF1: a role in mitohormesis
   Pau B. Esparza-Moltó et al, 2017, Cell. Mol. Life Sci. CrossRef
2. Overexpression of the ATPase Inhibitory Factor 1 Favors a Non-metastatic Phenotype in Breast Cancer
   Lucía García-Ledo et al, 2017, Front. Oncol. CrossRef
3. Systematic review of plasma-membrane ecto-ATP synthase: A new player in health and disease
   Taurino Federica et al, 2018, Experimental and Molecular Pathology CrossRef
4. The Role of Mitochondrial H+-ATP Synthase in Cancer
   Pau B. Esparza-Moltó et al, 2018, Front. Oncol. CrossRef
5. null
   Kenneth J. Dornfeld et al, 2018 CrossRef
6. The role of the ATPase inhibitor factor 1 (IF 1 ) in cancer cells adaptation to hypoxia and anoxia
   G. Sgarbi et al, 2018, Biochimica et Biophysica Acta (BBA) - Bioenergetics CrossRef
7. F1F0-ATP Synthase Inhibitory Factor 1 in the Normal Pancreas and in Pancreatic Ductal Adenocarcinoma: Effects on Bioenergetics, Invasion and Proliferation
   Helen Tanton et al, 2018, Front. Physiol. CrossRef
8. Nicotinic acid inhibits glioma invasion by facilitating Snail1 degradation
   Jiejing Li et al, 2017, Sci Rep CrossRef
9. Control of Mitochondrial Remodeling by the ATPase Inhibitory Factor 1 Unveils a Pro-survival Relay via OPA1
   Danilo Faccenda et al, 2017, Cell Reports CrossRef
10. Pyruvate kinase M2 and the mitochondrial ATPase Inhibitory Factor 1 provide novel biomarkers of dermatomyositis: a metabolic link to oncogenesis
    Fulvio Santacatterina et al, 2017, J Transl Med CrossRef
11. Oncogenic pathways and the electron transport chain: a dangeROS liaison
    Vittoria Raimondi et al, 2019, Br J Cancer CrossRef
12. Overexpression of Mitochondrial IF1 Prevents Metastatic Disease of Colorectal Cancer by Enhancing Anoikis and Tumor Infiltration of NK Cells
    Lucía González-Llorente et al, 2019, Cancers CrossRef
13. Metabolic reprogramming and disease progression in cancer patients.
    Laura Torresano et al, 2020, Biochim Biophys Acta Mol Basis Dis CrossRef
14. Changing perspective on oncometabolites: from metabolic signature of cancer to tumorigenic and immunosuppressive agents
    Mauro Corrado et al, 2016, Oncotarget CrossRef
15. ATPase Inhibitory Factor 1 Promotes Hepatocellular Carcinoma Progression After Insufficient Radiofrequency Ablation, and Attenuates Cell Sensitivity to Sorafenib Therapy
    Jian Kong et al, 2020, Front. Oncol. CrossRef
16. ATPase inhibitory factor 1 inhibition improves the antitumor of YC‑1 against hepatocellular carcinoma
    Xuemei Ding et al, 2018, Oncol Lett CrossRef
17. Coordinate β-adrenergic inhibition of mitochondrial activity and angiogenesis arrest tumor growth
    Cristina Nuevo-Tapioles et al, 2020, Nat Commun CrossRef
18. The role of mitochondrial ATP synthase in cancer
    Chiara Galber et al, 2020 CrossRef
19. The F1Fo-ATPase inhibitor, IF1, is a critical regulator of energy metabolism in cancer cells
    Giancarlo Solaini et al, 2021 CrossRef
20. In Vivo Study of the Efficacy and Safety of 5-Aminolevulinic Radiodynamic Therapy for Glioblastoma Fractionated Radiotherapy
    Junko Takahashi et al, 2021, IJMS CrossRef
21. The multifaceted ATPase inhibitory factor 1 (IF1) in energy metabolism reprogramming and mitochondrial dysfunction: a new player in age-associated disorders?
    Emilia Gore et al, 2021, Antioxidants & Redox Signaling CrossRef
22. Norepinephrine inhibits migration and invasion of human glioblastoma cell cultures possibly via MMP-11 inhibition.
    Jing Zhong et al, 2021, Brain Res CrossRef
23. The F1Fo-ATPase inhibitor protein IF1 in pathophysiology
    Cristina Gatto et al, 2022, Front. Physiol. CrossRef
24. The ATPase Inhibitory Factor 1 (IF1) Contributes to the Warburg Effect and Is Regulated by Its Phosphorylation in S39 by a Protein Kinase A-like Activity
    José M. Cuezva et al, 2024, Cancers CrossRef
25. Peptides Targeting the IF1–ATP Synthase Complex Modulate the Permeability Transition Pore in Cancer HeLa Cells
    Martina Grandi et al, 2024, IJMS CrossRef